The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models
Ontology highlight
SUBMITTER: Masanas M
PROVIDER: S-EPMC8516339 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA